# Loss of CXCR5 expression and monocyte epithelial–mesenchymal transition are blood‐borne signatures of sterile granulomatous diseases

**Authors:** Yuwei Hao, Anthea Anantharajah, Jane M Wells, Lyndell L Lim, Anthony JH Hall, Gary YJ Chew, Matthew C Cook

PMC · DOI: 10.1002/cti2.70039 · Clinical & Translational Immunology · 2025-06-03

## TL;DR

This study compares blood markers in two granulomatous diseases and finds shared and unique features, including CXCR5 down-regulation in one and antigen-driven responses in the other.

## Contribution

Identifies blood-based signatures distinguishing tattoo uveitis from sarcoidosis and reveals shared inflammatory monocyte and EMT features in sterile granulomatous diseases.

## Key findings

- Active TU is marked by CXCR5 down-regulation on B cells and CD4+ T cells, which normalizes during remission.
- Both TU and sarcoidosis show monocyte epithelial–mesenchymal transition gene signatures in active disease.
- Sarcoidosis exhibits antigen-driven T cell responses, while TU does not.

## Abstract

Sarcoidosis is the exemplar sterile granulomatous disease and can affect any organ system. Tattoo uveitis (TU) resembles sarcoidosis clinically and histologically but is distinguished by the absence of systemic lymphadenopathy, with inflammation restricted to skin and eyes. In this study, our objectives were, first, to resolve whether TU is a subset of sarcoidosis or a different antigen‐driven condition and, second, by comparing TU and sarcoidosis, to identify blood‐borne signatures of active and quiescent sterile granulomatous diseases.

We recruited patients with active and inactive TU, sarcoidosis and healthy controls on whom we performed blood cell phenotyping and transcriptomics.

Unlike sarcoidosis, active TU is characterised by marked CXCR5 down‐regulation on B cells and CD4+ T cells that normalises on remission. TCR‐VDJ sequencing reveals an antigen‐driven response in sarcoidosis, but not in TU, with clonally expanded cytotoxic and terminally differentiated CD8+ effectors. Both active TU and sarcoidosis exhibit gene signatures of epithelial‐to‐mesenchymal transition (EMT) in circulating monocytes, whereas epithelioid macrophages are a hallmark of active granulomas.

We have identified both shared and specific phenotypes in TU and sarcoidosis. Marked CXCR5 down‐regulation occurs in active TU and could explain the unique absence of lymphadenopathy. Both TU and sarcoidosis are characterised by inflammatory monocyte phenotypes and transcriptional signatures of EMT.

Tattoo uveitis (TU) resembles sarcoidosis but is distinguished by the absence of systemic lymphadenopathy despite inflammation of skin and eyes. In this study, we compared blood‐borne signatures of these two diseases and found that both are characterised by inflammatory monocytes and transcriptional signatures of epithelial–mesenchymal transition, but CXCR5 down‐regulation occurs in TU, while sarcoidosis appears to be antigen‐driven.

## Linked entities

- **Genes:** CXCR5 (C-X-C motif chemokine receptor 5) [NCBI Gene 643]
- **Diseases:** sarcoidosis (MONDO:0008399)

## Full-text entities

- **Genes:** CXCR5 (C-X-C motif chemokine receptor 5) [NCBI Gene 643] {aka BLR1, CD185, MDR15}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, TRBV20OR9-2 (T cell receptor beta variable 20/OR9-2 (non-functional)) [NCBI Gene 6962] {aka CDR3, TCRBV20S2, TCRBV2O, TCRBV2S2O}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}
- **Diseases:** granulomatous disease (MESH:D006105), granulomas (MESH:D006099), lymphadenopathy (MESH:D008206), inflammation (MESH:D007249), TU (MESH:C567128), Sarcoidosis (MESH:D012507), sterile granulomatous diseases (MESH:D007246)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12133384/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12133384/full.md

## References

53 references — full list in the complete paper: https://tomesphere.com/paper/PMC12133384/full.md

---
Source: https://tomesphere.com/paper/PMC12133384